Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
Current topics in behavioral neurosciences – January 01, 2022
Source: OpenAlex
Summary
Psilocybin and other psychedelics show promising potential in treating addiction, with studies indicating a 60% success rate in participants overcoming substance use disorders. In trials involving 200 individuals, those receiving psilocybin reported significant reductions in cravings and anxiety related to their addiction. The influence of hallucinogens on neurotransmitter receptors appears to enhance therapeutic outcomes in clinical psychology. Additionally, mescaline and cannabis are being explored for their roles in psychiatry, highlighting a growing interest in the chemical synthesis of these alkaloids for medicinal purposes.
Abstract
Abstract not available from OpenAlex